$451 Million is the total value of venBio Partners LLC's 10 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $163,929,000 | -21.4% | 9,699,925 | 0.0% | 36.34% | -3.2% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $75,139,000 | -35.7% | 1,544,484 | -43.6% | 16.66% | -20.9% |
| VENTYX BIOSCIENCES INC | $68,007,000 | -31.7% | 5,011,536 | 0.0% | 15.08% | -15.9% | ||
| PHVS | PHARVARIS N V | $41,771,000 | +26.0% | 2,303,310 | 0.0% | 9.26% | +55.1% | |
| New | CINCOR PHARMA INC | $34,742,000 | – | 1,980,706 | +100.0% | 7.70% | – | |
| AKRO | AKERO THERAPEUTICS INC | $30,816,000 | -32.9% | 2,171,664 | 0.0% | 6.83% | -17.4% | |
| IMPL | IMPEL NEUROPHARMA INC | $17,580,000 | -26.2% | 2,759,791 | 0.0% | 3.90% | -9.2% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $11,718,000 | +11.1% | 3,673,374 | 0.0% | 2.60% | +36.8% | |
| ELEV | ELEVATION ONCOLOGY INC | $6,573,000 | -58.1% | 2,608,167 | 0.0% | 1.46% | -48.5% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $808,000 | -25.7% | 161,897 | 0.0% | 0.18% | -8.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.